$178.04 -1.66 (%) Allergan Inc - NYSE

Sep. 30, 2014 | 12:00 PM

Partner Headlines

  1. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  2. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD | Sep. 29, 2014 | 18:32PM EST
  3. Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance

    IBD | Sep. 29, 2014 | 13:32PM EST
  4. UPDATE: Allergan Board Offers Statement, Says Valeant's Bid 'Grossly Inadequate'

    Benzinga | Sep. 29, 2014 | 08:05AM EST
  5. Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix

    Benzinga | Sep. 28, 2014 | 11:05AM EST
  6. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD | Sep. 27, 2014 | 08:02AM EST
  7. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 26, 2014 | 08:02AM EST
  8. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  9. Valeant: Glaucoma Drug Is Potential Blockbuster

    IBD | Sep. 25, 2014 | 13:47PM EST
  10. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga | Sep. 24, 2014 | 21:09PM EST
  11. Pharma Buyout Bids Beat On

    IBD | Sep. 24, 2014 | 18:55PM EST
  12. Valeant Ends Prince Charming Act; Allergan Hopes Rise

    IBD | Sep. 24, 2014 | 15:55PM EST
  13. #PreMarket Primer: Wednesday, September 24: US Economy Looking Strong In The Third Quarter

    Benzinga | Sep. 24, 2014 | 07:13AM EST
  14. Ackman forewarns Allergan

    IBD | Sep. 23, 2014 | 18:45PM EST
  15. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  16. Stocks Finish Lower Among Takeover Rumors

    IBD | Sep. 23, 2014 | 18:06PM EST
  17. Dow Down 0.6%; CarMax Shares Fall After Q2 Results

    Benzinga | Sep. 23, 2014 | 15:13PM EST
  18. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  19. Ascena Retail Drops On Downbeat Earnings; CF Industries Shares Gain

    Benzinga | Sep. 23, 2014 | 12:43PM EST
  20. Stocks Fall Modestly; New Issue Alibaba Extends Losses

    IBD | Sep. 23, 2014 | 11:56AM EST
  21. Allergan-Ackman Flame War Reignites On Salix Rumors

    IBD | Sep. 23, 2014 | 11:47AM EST
  22. Markets Mixed; Carnival Profit Tops Street View

    Benzinga | Sep. 23, 2014 | 11:20AM EST
  23. Benzinga's Volume Movers

    Benzinga | Sep. 23, 2014 | 10:25AM EST
  24. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 23, 2014 | 10:10AM EST
  25. Morning Market Movers

    Benzinga | Sep. 23, 2014 | 09:38AM EST
  26. Stock Futures Lower, But Salix Soars On Buyout Talk

    IBD | Sep. 23, 2014 | 08:55AM EST
  27. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 23, 2014 | 08:14AM EST
  28. #PreMarket Primer: Tuesday, September 23: First Airstrikes In Syria Begin

    Benzinga | Sep. 23, 2014 | 07:28AM EST
  29. US Stock Futures Fall Ahead Of Economic Data

    Benzinga | Sep. 23, 2014 | 07:16AM EST
  30. Stocks To Watch For September 23, 2014

    Benzinga | Sep. 23, 2014 | 05:24AM EST
  31. Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

    Benzinga | Sep. 22, 2014 | 22:50PM EST
  32. Benzinga's M&A Chatter for Monday September 22, 2014

    Benzinga | Sep. 22, 2014 | 18:17PM EST
  33. Auxilium Mulls Endo Bid; Is $2.2 Billion Enough?

    IBD | Sep. 17, 2014 | 18:07PM EST
  34. Auxilium Mulls Endo Bid; Street Eyes A Higher Price

    IBD | Sep. 17, 2014 | 11:47AM EST
  35. Valeant, Allergan settle suit

    IBD | Sep. 16, 2014 | 18:53PM EST
  36. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD | Sep. 16, 2014 | 11:36AM EST
  37. Ackman's New Fund Could Spur More Market Activism

    IBD | Sep. 15, 2014 | 12:22PM EST
  38. Pershing Square Submiterd Additional Special Meeting Requests On Friday, Total Submitted Represents 35.68% Of Allergan Shares

    Benzinga | Sep. 15, 2014 | 11:57AM EST
  39. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  40. Allergan Comments On Pershing Square's Delivery Of Additional Requests From Stockholders Owning 1.5% Of Allergan's Shares

    Benzinga | Sep. 11, 2014 | 20:46PM EST
  41. Bill Ackman Rips Allergan, Inc. In Letter

    Benzinga | Sep. 10, 2014 | 11:56AM EST
  42. William Ackman Sends Letter To Allergen Board

    Benzinga | Sep. 9, 2014 | 15:56PM EST
  43. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  44. Jazz Pharmaceuticals Up On Allergan, Inc. Rumor

    Benzinga | Sep. 5, 2014 | 15:53PM EST
  45. Stocks Rise, Turn Positive Going Into Final Hour

    IBD | Sep. 5, 2014 | 15:16PM EST
  46. Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

    IBD | Sep. 3, 2014 | 18:28PM EST
  47. Allergan Reports Filing of Answer in Federal Court Related to Valeant, Pershing Square's Counterclaims

    Benzinga | Sep. 2, 2014 | 09:04AM EST
  48. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD | Aug. 27, 2014 | 08:02AM EST
  49. S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue To Rally

    Benzinga | Aug. 26, 2014 | 16:42PM EST
  50. 3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology

    Benzinga | Aug. 24, 2014 | 20:08PM EST
Trading Center